Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role Of Prophylactic Urethral Stenting With Memokath® 028SW in Patients Undergoing Prostate 125I Seed Implants For Prostate Carcinoma: A Phase I/II Study

NCT00252941 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00252941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role Of Prophylactic Urethral Stenting With Memokath® 028SW in Patients Undergoing Prostate 125I Seed Implants For Prostate Carcinoma: A Phase I/II Study
Lead sponsor
The Cleveland Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2005
Completion date
November 30, 2006
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-brachytherapy bladder outlet obstruction, prostate cancer